Review Article
Other versions:
- ContentsContents
- Article InfoArticle Info
- CitationCitation
- MetricsMetrics
- CommentComment
- RelatedRelated
- TabsTabs
- RefsRefs
- CitedCited
-
Article title
-
Abstract
-
Keywords
-
Introduction
-
Abbreviations
-
Current mAb cancer therapies
-
Limitations of current mAbs
-
Emerging alternatives
-
Bispecific antibodies (BsAbs)
-
Antibody fragments
-
Antibody-Drug Conjugates (ADCs)
-
Nanobodies (or nanocomponents)
-
Intrabodies (or intracellular antibodies)
-
Stereospecific and catalytic mAbs
-
Combination immunotherapies
-
Small immunotherapeutic molecules
-
-
Conclusion
-
References
-
Author contributions